Published 11 days ago • loading... • Updated 10 days ago

Axplora Invests €50 Million in GLP-1 Manufacturing at its French Site

Summary by GEN - Genetic Engineering and Biotechnology News…

Germany-based Axplora says it has invested €50 million ($51.8 million) in its Mourenx site in Southwest France. Axplora specializes in large-scale API industrial chemistry and chromatography with a focus on cardiovascular and metabolic diseases. By upgrading Mourenx’s infrastructure and capabilities, Axplora expects to strengthen its position in peptide purification in a biologics environment and support the development of next-generation therap…

3 Articles

All

Left

Center

Right

pharmtech.com

Axplora Makes €50 Million Investment in GLP-1 Manufacturing in France

This site was previously the beneficiary of a €7.3 million (US$7.6 million) investment, made in 2022, earmarked for the production of HPAPIs to treat cancer.

10 days ago

Read Full Article

Express Pharma

Axplora invests €50 million in Mourenx Site to expand API and biologics manufacturing - Express Pharma

Axplora has announced a €50 million investment in its Mourenx site in Southwest France to expand its API small molecule and ADC manufacturing capabilities. The development aims to strengthen the site’s role in producing APIs and drug substances for FDA-approved biologics. The investment will upgrade Mourenx’s infrastructure and enhance its peptide purification capabilities in a biologics environment. This will support the development of next-gen…

10 days ago

Read Full Article